Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities Notes

The Blood-Brain Barrier (BBB) is a semipermeable membrane that protects the brain by preventing harmful substances from entering, maintaining a stable environment, and facilitating nutrient transport. It consists of endothelial cells, pericytes, astrocytes, and the basal lamina.

The Neurovascular Unit includes neuronal and glial elements that respond to ischemic strokes with neuroinflammation, activating microglia and astrocytes that produce cytokines leading to leukocyte infiltration.

Brain Ischemia involves neuroinflammation that reacts to harmful stimuli and is characterized by cellular changes aimed at repair but can lead to further damage if overactivated. Focal Brain Ischemia occurs from blood flow obstruction, resulting in neuronal loss and ischemic stroke, primarily due to thrombus or embolism.

The stroke is divided into phases:

• Hyperacute (less than 6 hours): Initial BBB disruption.

• Acute (6-72 hours): Neuroinflammation and immune infiltration.

• Subacute (longer than 72 hours): Recovery processes.

• Chronic (greater than 4 weeks): BBB restoration and neurogenesis.

Mechanisms of BBB damage include oxidative stress, matrix metalloproteinases (MMPs), inflammatory mediators, and the infiltration of peripheral immune cells.

Imaging modalities such as BBB permeability, immune cell imaging, and molecular markers are crucial in diagnosing and analyzing neuroinflammation. However, translating these findings to clinical applications remains challenging due to differences between species and the complexities of human neuroinflammation. Effective treatments for BBB and neuroinflammation post-stroke include tPA, anti-inflammatory agents, and research on stem cell therapies. Evaluating timing of treatments and imaging techniques is vital for optimizing recovery and minimizing neural damage.